CING: Cingulate Inc. Stock

by  •  • Comments Off on CING: Cingulate Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 12.75
Enterprise Value ($M) 2.70
Book Value ($M) 12.04
Book Value / Share 3.65
Price / Book 1.06
NCAV ($M) 9.80
NCAV / Share 2.97
Price / NCAV 1.30

Profitability (mra)
Return on Invested Capital (ROIC) -1.33
Return on Assets (ROA) -4.68
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 7.35
Current Ratio 7.35

Balance Sheet (mrq) ($M)
Current Assets 11.34
Assets 13.58
Liabilities 1.54
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G/A Lind Global Fund II LP 3.10 -64.92
08-30 13D/A Werth Peter J. 4.51 0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2024-04-01 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-13 23,443 107,660 21.78
2025-03-12 17,248 51,295 33.63
2025-03-11 38,119 109,274 34.88
2025-03-10 19,584 50,995 38.40
2025-03-07 14,617 42,095 34.72

(click for more detail)

Similar Companies
CELU – Celularity Inc. CELZ – Creative Medical Technology Holdings, Inc.
CGEN – Compugen Ltd. CKPT – Checkpoint Therapeutics, Inc.
CLDX – Celldex Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io